← All indications
Carcinoma, Endometrioid
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
Drugs by status
Phase 2 trials (11)
Phase 1 trials (5)
Other trials (5)
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (28)
- Foundation Medicine
- Takeda
- Bristol-Myers Squibb
- Clovis Oncology
- Astellas
- Medivation
- Genentech
- Novartis
- Syndax Pharmaceuticals
- Brown University
- Harvard University
- University of Washington
- MedSIR
- North Eastern Germany Society of Gynaecologic Oncology
- Southwest Oncology Group
- University of Oklahoma
- University of Toronto
- Mayo Clinic
- University of Chicago
- Vanderbilt University
- University of Queensland
- University of Texas at Houston
- State University of New York, Buffalo
- University of Wisconsin
- National Comprehensive Cancer Network
- Queensland University of Technology
- Yeshiva University
- Imperial College London
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (1)